We are live on
!
Find out more
CIM
Contravisory Investment Management Portfolio holdings
AUM
$566M
1-Year Est. Return
42.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$450M
AUM Growth
–
Cap. Flow
+$452M
Cap. Flow
% of AUM
100.52%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
133
New
133
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$16.2M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$15.7M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$14.3M |
| 4 |
Moody's
MCO
|
+$13.6M |
| 5 |
Community Health Systems
CYH
|
+$13.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.03% |
| 2 | Industrials | 15.7% |
| 3 | Healthcare | 14.53% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Materials | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$161B
| $15.9M | 3.53% |
+310,026
| New | +$16.2M |
|
|
PARA
2
DELISTED
Paramount Global Class B
PARA
| $15.3M | 3.39% |
+312,444
| New | +$14.3M |
|
|
KSU
3
DELISTED
Kansas City Southern
KSU
| $15.3M | 3.39% |
+143,924
| New | +$15.7M |
|
|
4
Community Health Systems
CYH
$385M
| $14M | 3.1% |
+360,383
| New | +$13.6M |
|
|
5
Moody's
MCO
$81.7B
| $13.6M | 3.03% |
+223,804
| New | +$13.6M |
|
6
American International
AIG
$41.9B
| $13.2M | 2.94% |
+296,140
| New | +$12.7M |
|
7
Mastercard
MA
$477B
| $12.6M | 2.79% |
+218,480
| New | +$12.1M |
|
8
Northern Trust
NTRS
$22.2B
| $12.2M | 2.72% |
+211,397
| New | +$11.8M |
|
9
Cincinnati Financial
CINF
$28.3B
| $12.1M | 2.7% |
+264,272
| New | +$12.6M |
|
10
Amgen
AMGN
$203B
| $11.8M | 2.61% |
+119,109
| New | +$12.4M |
|
|
RTN
11
DELISTED
Raytheon Company
RTN
| $11.7M | 2.6% |
+176,873
| New | +$11.2M |
|
12
American Water Works
AWK
$26.3B
| $11.6M | 2.58% |
+281,475
| New | +$11.6M |
|
13
Ashland
ASH
$3.04B
| $11.4M | 2.53% |
+278,446
| New | +$11.6M |
|
14
Colgate-Palmolive
CL
$72.6B
| $11.4M | 2.52% |
+198,164
| New | +$11.8M |
|
|
SNDK
15
DELISTED
SANDISK CORP
SNDK
| $11.3M | 2.52% |
+185,736
| New | +$10.6M |
|
16
Autoliv
ALV
$8.6B
| $11.3M | 2.52% |
+203,155
| New | +$11M |
|
17
Ford
F
$57.3B
| $11.3M | 2.51% |
+729,442
| New | +$10.5M |
|
18
CVS Health
CVS
$137B
| $11.3M | 2.5% |
+197,051
| New | +$11.4M |
|
|
MON
19
DELISTED
Monsanto Co
MON
| $11.2M | 2.5% |
+113,856
| New | +$11.9M |
|
20
Cintas
CTAS
$82.4B
| $11.1M | 2.46% |
+971,260
| New | +$11M |
|
|
SNI
21
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $11M | 2.44% |
+164,209
| New | +$11M |
|
22
Church & Dwight Co
CHD
$23.1B
| $10.9M | 2.43% |
+354,448
| New | +$11.1M |
|
23
D.R. Horton
DHI
$41B
| $10.9M | 2.42% |
+511,085
| New | +$12.4M |
|
24
Verisk Analytics
VRSK
$26.4B
| $10.7M | 2.38% |
+179,186
| New | +$10.7M |
|
|
INVX
25
Innovex International
INVX
$1.87B
| $10.7M | 2.37% |
+118,308
| New | +$10.4M |
|
Similar funds
FG
SAM
BCMLT
KJWM
PAM
PEP
OC
LC
Contravisory Investment Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Contravisory Investment Management, which disclosed 133 positions worth $450M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Gilead Sciences: 310,026 shares worth $15.9M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Industrials and Healthcare.
- Contravisory Investment Management's largest Q2 2013 buy was Gilead Sciences: 310,026 shares worth $15.9M.
- Contravisory Investment Management's ten largest holdings make up 30% of its $450M portfolio in Q2 2013.
- Contravisory Investment Management disclosed 133 positions in Q2 2013, its first 13F filing on record.
Based on Contravisory Investment Management's 13F filing for Q2 2013, filed 15 Jul 2013.